StockData

Neutra Corp. (NTRR) stock

NTRROTCMedicinal Chemicals & Botanical ProductsFiscal year ends January 31
Số liệu tài chính tới Q3 năm tài chính 2024, quý kết thúc ngày Oct 31, 2023Last filing: 10-Q on Aug 7, 2024
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Neutra Corp. saw revenue fall 82.7% to $17.40K over the twelve months to Oct 31, 2023.

Revenue
$17.40K
-82.7% vs. a year earlier
Operating income
-$253.49K
TTM Q3 2024

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Oct 31, 2023

Valuation

Market cap
–
P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–
Free cash flow yield
–

Fundamentals

Revenue
$17.40K
Net income
-$473.83K

Trading

Previous close
$0.00
Open
$0.00
Day's range
$0.00 – $0.00
Volume
5,921,427
Average volume (20 days)
8,517,814

Market cap history

Month-end market cap since 2011, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodNTRRS&P 500DifferenceNTRR per yearS&P 500 per year
1 month0.0%+0.6%−0.6 pts
3 months0.0%+3.4%−3.4 pts
Year to date0.0%+13.3%−13.3 pts
1 year-50.0%+16.6%−66.6 pts
3 years-71.4%+86.4%−157.8 pts-34.1%+23.1%
5 years-97.0%+81.9%−178.8 pts-50.3%+12.7%
10 years-100.0%+318.9%−418.8 pts-58.1%+15.4%

Thirteen years at a glance

Fiscal years 2011 to 2023 and trailing twelve months, USD

Revenue

$17.40K-82.7% YoY

Gross profit

$8.03K-86.9% YoY

Operating income

-$253.49K

Net income

-$473.83K

EPS, diluted

–

Free cash flow

–
Reported periodTrailing twelve months

About Neutra

Medicinal Chemicals & Botanical Products

Neutra Corp. operates in the nutraceutical and cannabis sectors, focusing on products derived from natural and organic sources. The company primarily offers hemp-derived items, including products containing delta-8-THC, cannabidiol (CBD) sports creams, and other cannabinoids. In addition to commercializing products, it engages in research and development to introduce new technologies into the nutraceutical industry, targeting applications such as lighting, dosage devices, pesticide replacements, and plant enhancers. The company distributes its offerings to consumers both online through marketing agreements and under its own unique brands, utilizing third-party contract manufacturers for private-label production.

Company profile, executives and history

Neutra stock: common questions

What is Neutra's stock price?

NTRR closed at $0.00 on Oct 19, 2026, up 0.00% on the day.

How much revenue does Neutra make?

Neutra reported revenue of $17.40K for the twelve months to Oct 31, 2023, down 82.7% from a year earlier.

Does Neutra pay a dividend?

No. Neutra has not paid a cash dividend over the last twelve months.

How has NTRR stock performed over the past year?

Including dividends, NTRR returned -50.0% over the past year, against +16.6% for the S&P 500.

Who are Neutra's competitors?

Companies most similar to Neutra by business, industry and size include HYEX, TCRG, PLSH, NPHC, CRLBF.

See a number that looks wrong?